Trials / Completed
CompletedNCT03414541
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase IIa Study To Assess The Safety And Efficacy Of Orally Administered DS102 In Chronic Obstructive Pulmonary Disease Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Afimmune · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this randomised, double-blind, placebo-controlled, parallel group study is to assess the safety and efficacy of orally administered DS102 capsules versus placebo in the treatment of adult patients with Chronic Obstructive Pulmonary Disease (COPD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS102 | DS102 |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2017-09-24
- Primary completion
- 2019-01-11
- Completion
- 2019-01-29
- First posted
- 2018-01-30
- Last updated
- 2020-01-31
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03414541. Inclusion in this directory is not an endorsement.